TORONTO, Oct. 24,
2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN)
(TSX: DHT.U) (the "Trust") announces that it will hold a conference
call to discuss its third quarter 2023 financial results on
Tuesday, November 14, 2023, at
8:00 a.m. ET. The Trust will report
its financial results on Monday, November
13, 2023, after market close.
All interested parties may join the conference call by dialing
416-764-8659 or 1-888-664-6392 approximately 15 minutes prior to
the call to secure a line. Participants will be put on hold until
the conference call begins. A question-and-answer session will
follow management's prepared remarks, at which time the operator
will provide instructions for qualified equity analysts to submit
questions.
A live webcast of the conference call, including a slide
presentation, will be available at http://bit.ly/DRIQ32023. Please
connect at least 15 minutes prior to the conference call to ensure
adequate time for any software download that may be required to
join the webcast. The webcast will be archived on the Trust's
website following the call date.
About DRI Healthcare Trust
DRI Healthcare Trust is managed by DRI Capital Inc. ("DRI
Capital"), the pioneer in global pharmaceutical royalty
monetization with a more than 30-year history of accelerating
innovation by providing capital to inventors, academic institutions
and biopharma companies. Since our founding in 1989, DRI Capital
has deployed more than US$2.5
billion, acquiring more than 70 royalties on 40-plus drugs,
including Eylea, Keytruda, Orserdu, Spinraza, Stelara, Vonjo,
Zejula, and Zytiga. DRI Healthcare Trust's units are listed and
trade on the Toronto Stock Exchange in Canadian dollars under the
symbol "DHT.UN" and in U.S. dollars under the symbol "DHT.U". To
learn more, visit drihealthcare.com or follow us on LinkedIn.
SOURCE DRI Healthcare Trust
